SANTEN PHARMACEUTICAL CO.,LTD.
4536 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 大阪市北区大深町４番２０号
- Website:
- https://www.santen.com/en
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Santen Pharmaceutical Co., Ltd. is a leading Japanese company specializing in eye health, dedicated to enhancing the well-being of individuals through innovative pharmaceutical products and services. With a mission to achieve “Happiness with Vision,” Santen supports the eye health of approximately 50 million people globally by engaging in extensive research and development, manufacturing, and marketing of eye care solutions. Committed to sustainability, the company integrates environmental, social, and governance (ESG) principles into its operations, prioritizing long-term strategies that create shared value and advance societal well-being. Santen's focus on eye care underscores its leadership in the field and its dedication to improving quality of life through vision health.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-15 04:38 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 25.2 KB | |
| 2025-06-25 04:08 |
Inside Information Statement
臨時報告書
|
Japanese | 26.5 KB | |
| 2025-06-24 09:22 |
Inside Information Statement
臨時報告書
|
Japanese | 32.1 KB | |
| 2025-06-23 08:29 |
Internal Control over Financial Reporting
内部統制報告書－第113期(2024/04/01－2025/03/31)
|
Japanese | 24.3 KB | |
| 2025-06-23 08:28 |
Regulatory News Service
確認書
|
Japanese | 8.5 KB | |
| 2025-06-23 08:27 |
Annual Report
有価証券報告書－第113期(2024/04/01－2025/03/31)
|
Japanese | 2.2 MB | |
| 2025-06-13 04:35 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 22.1 KB | |
| 2025-04-15 06:53 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 21.3 KB | |
| 2025-03-13 03:29 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 23.8 KB | |
| 2025-02-14 02:01 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 21.3 KB | |
| 2025-01-15 06:49 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 23.0 KB | |
| 2024-12-13 03:01 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 28.5 KB | |
| 2024-11-14 05:33 |
Transaction in Own Shares
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
|
Japanese | 23.7 KB | |
| 2024-11-11 07:32 |
Regulatory News Service
確認書
|
Japanese | 8.6 KB | |
| 2024-11-11 07:30 |
Interim Report
半期報告書－第113期(2024/04/01－2025/03/31)
|
Japanese | 311.2 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
AnGes, Inc. | Japan | 4563 |